+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Brain Hemorrhage Drug"

Brain Hemorrhage - Pipeline Insight, 2024 - Product Thumbnail Image

Brain Hemorrhage - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 75 Pages
  • Global
From
From
Brain Hemorrhage - Epidemiology Forecast to 2032 - Product Thumbnail Image

Brain Hemorrhage - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Brain Hemorrhage Disease - Global Clinical Trials Review, H2 2020 - Product Thumbnail Image

Brain Hemorrhage Disease - Global Clinical Trials Review, H2 2020

  • Clinical Trials
  • October 2020
  • 184 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Brain hemorrhage drugs are a type of central nervous system (CNS) drug used to treat bleeding in the brain. These drugs are typically administered intravenously and work by reducing the pressure in the brain, which helps to stop the bleeding. They can also be used to reduce the risk of further bleeding and to reduce the risk of stroke. Common side effects of brain hemorrhage drugs include headache, nausea, and dizziness. Brain hemorrhage drugs are used to treat a variety of conditions, including aneurysms, arteriovenous malformations, and subarachnoid hemorrhages. They are also used to treat traumatic brain injuries, such as those caused by a car accident or a fall. The brain hemorrhage drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, and Sanofi. Other companies in the market include GlaxoSmithKline, AstraZeneca, and Johnson & Johnson. Show Less Read more